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Chlorosulfonic acidAbstract Chlorosulfonic acid (ClSO3H) used to be a catalyst for the synthesis of 2-aryl-1-aryl-
methyl-1H-benzimidazoles which was efﬁciently simple and convenient. This method afforded short
reaction time, easy workup, moderate to excellent isolated yields which make this protocol practical
and economically attractive.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Interest in benzimidazole containing structures stems from
their widespread occurrence in molecules that exhibit signiﬁ-
cant activity against several virus such as HIV (Porcari et al.,
1998), herpes (HSV-1) (Migawa et al., 1998), RNA and human
cytomegalovirus (HCMV) (Tamm and Seghal, 1978). In addi-
tion, benzimidazole derivatives are also used as potential anti-
tumour agents, smooth muscle cell proliferation inhibitors,
antimicrobial agents, a treatment for interstitial cystitis, as fac-
tor Xa inhibitors and in diverse areas of chemistry (Stevenson
et al., 1999; Zhao et al., 2000; Forseca et al., 2001). In light ofthe afﬁnity they display toward a variety of enzymes and pro-
tein receptors medicinal chemists would certainly classify them
as ‘privileged sub-structures’ for drug design (Mason et al.,
1999). Therefore the preparation of benzimidazoles has gained
considerable attention in recent years.
The traditional synthesis of benzimidazoles involves the
reaction between an o-phenylenediamine and a carboxylic acid
or its derivatives (nitriles, amidates orthoesters) under harsh
dehydrating conditions (Preston et al., 1981; Chi and Sun,
2000; Huang and Scarborough, 1999). Benzimidazoles have
also been prepared on solid phase to provide a combinatorial
approach (Wu et al., 2000). The most popular strategies for
their synthesis utilize o-nitroanilines as intermediates or resort
to direct N-alkylation of an unsubstantiated benzimidazole
(Kim et al., 2004; Itoh et al., 2004). A number of synthetic pro-
tocols that involve intermediate o-nitroanilines have evolved to
include the synthesis of benzimidazoles on solid support
(Tumelty et al., 2001, Kilburn et al., 2000). Another method
for the synthesis of these compounds is the reaction of o-phen-
ylenediamine with aldehydes in the presence of acidic catalysts
under various reaction conditions (Pertry and Wilson, 1993;
Esser et al., 1999; Brain and Brunton, 2002; Perumal et al.,
Table 2 Synthesis of 2-aryl-1-arylmethyl-1H-benzimidazole.
Entry R Reaction time (h) Yield (%)a M.p. (C)
3a C6H5 1.8 93 132–134
3b 4-Cl–C6H4 2.2 84 237–239
3c 4-CH3 C6H4 2 88 126–128
3d 2-Cl–C6H4 2.4 80 154–156
3e 4-NO2–C6H4 3.2 91 192–194
3f 2-NO2–C6H4 3.3 82 118–120
3g 4-(CH3)2N–C6H4 2.6 92 252–254
3h 4-OCH3–C6H4 2.1 85 130–131
3i C4H3O 2.3 88 96–98
3j 2-OCH3–C6H4 2.1 87 151–153
Compounds 1 (10 mmol, 1.08 g), 2(a–j) (20 mmol, 2.12 g) and
chlorosulfonic acid (10 mol%, 0.11 g) in 2-propanol was stirred at
room temperature.
a Isolated yields.
Table 1 Optimization of reaction conditions and mol% of
chlorosulfonic acid for the synthesis of 2-aryl-1-arylmethyl-1H-
benzimidazoles.
Entry Solvent Mol% of ClSO3H Time (h) Yield (%)
1 DCM 0.10 3.3 80
2 Methanol 0.10 2.4 71
3 Acetonitrile 0.10 3.2 63
4 Ethanol 0.10 2.3 74
5 Chloroform 0.10 3.0 58
6 2-Propanol 0.10 1.8 93
7 2-Propanol 0.07 1.8 93
8 2-Propanol 0.05 1.8 93
9 2-Propanol 0.025 2.5 85
10 2-Propanol 0.001 3.0 78
Synthesis of 2-aryl-1-arylmethyl-1H-benzimidazoles using chlorosulfonic acid at room temperature S8592004; Sapkal et al., 2009; Salehi et al., 2006; Varala et al., 2007).
However many of these methods have several drawbacks such
as low use of expensive reagents a special oxidation process or
long reaction time, tedious work up procedures, co-occurrence
of several side reaction and low yield. Therefore the search con-
tinues for a better catalyst for the synthesis of benzimidazoles in
terms of operational simplicity and economical viability of
chlorosulfonic acid that was discovered in 1854 and soon be-
came a reagent of widespread use. It has found application in
many diverse types of reactions, such as alkylation, halogen-
ations, rearrangement, cyclization and polymerization, usually
operating as a strong acid catalyst and efﬁcient halogenationsSchemeand dehydrating agent (Cremylan, 2002). It is also used in the
synthesis of 14-aryl-14H-dibenzo[a,j]xanthenes derivatives un-
der microwave irradiation (Shelke et al., 2007).
2. Experimental
2.1. Materials and methods
All aldehydes were obtained from a freshly opened container
and used without further puriﬁcation with the exception of
benzaldehyde and 2-furaldehyde which were distilled prior to
use. Melting point was determined in open capillary tubes
and is uncorrected. IR spectra were recorded on Perkin Elmer
FTIR spectrophotometer in KBr disc, 1H NMR spectra were
recorded on variant 300 MHz spectrophotometer in CDCl3
using TMS as the internal standard. The chemical shifts have
been expressed in d-ppm scale, the melting points and other
data were recorded in Table 2. General procedure for the syn-
thesis of 2-aryl-1-arylmethyl-1H-benzimidazoles.
2.2. General procedure
A mixture of o-phenylenediamine (10 mmol, 1.08 g), aromatic
aldehyde (20 mmol, 2.12 g), and chlorosulfonic acid
(0.10 mol%, 0.11 g) in 2-propanol was stirred at room temper-
ature for appropriate time given in Table 2. After completion
of the reaction as indicated by TLC, the solvent was evapo-
rated on rota-vapor, the residue was poured on crushed ice
and the solid that was obtained which was ﬁltered. The solid
was recrystallized from ethanol to expecting the pure product
the results were summarized in Table 1. The structures of the
products were conﬁrmed by IR and 1H NMR spectral data
and were compared with authentic samples prepared according
to the literature method (Scheme 1).
2.3. Spectral data of some compounds
Compound 3a. M.p.: 132–134 C; 1H NMR (CDCl3,
500 MHz): 5.46 (s, 2H), 7.05 (d, 2H, J= 7.6 Hz), 7.25–7.28
(m, 5H), 7.53–7.58 (m, 4H), 7.75–7.80 (m, 3H).
Compound 3b. M.p.: 137–139 C; 1H NMR (CDCl3,
500 MHz): 5.21 (s, 2H), 7.11 (d, 2H, J= 8.6 Hz), 7.21–7.25
(m, 2H), 7.35 (d, 2H, J= 8.4 Hz), 7.48 (d, 1H, J= 8.6 Hz),
7.79 (d, 2H, J= 8.6 Hz), 7.70 (d, 3H, J= 8.4 Hz).
Compound 3c. M.p.: 126–128 C; 1H NMR (CDCl3,
500 MHz): 2.41 (s, 3H), 2.45 (s, 3H), 5.51 (s, 2H), 6.85 (d,
2H, J= 7.6 Hz), 7.10 (d, 2H, J= 7.6 Hz), 7.23–7.25 (m,
2H), 7.31 (d, 2H, J= 7.4 Hz), 7.45 (d, 1H, J= 7.4 Hz), 7.70
(d, 2H, J= 7.4 Hz), 7.76 (d, 1H, J= 7.4 Hz).1
S860 N.V. Shitole et al.Compound 3h. M.p.: 130–131 C; 1H NMR (CDCl3,
500 MHz): 3.60 (s, 3H), 3.89 (s, 3H), 5.53 (s, 2H), 6.88 (d,
2H, J= 8.6 Hz), 6.99 (d, 2H, J= 8.5 Hz), 7.04 (d, 2H,
J= 8.7 Hz), 7.21–7.26 (m, 2H), 7.55 (d, 1H, J= 8.1 Hz),
7.82 (d, 3H, J= 8.5 Hz).
3. Results and discussion
To evaluate the ability of chlorosulfonic acid in this reaction,
we report a simple synthesis of 2-aryl-1-arylmethyl-1H
-benzimidazole derivatives by the reaction of various aromatic
aldehydes with o-phenyldiamine in 2-propanol in the presence
of ClSO3H as a catalyst to establish the optimized condition,
we carried out a set of experiments varying the reaction time.
In 2-propanol the best condition to prepare 2-aryl-1-aryl-
methyl-1H-benzimidazoles was achieved when 0.10 mol% of
ClSO3H equivalent of aldehyde, o-phenyldiamine were mixed
and the reaction mixture was stressed at room temp for
2–3 h expecting the desired product in excellent yield. The abil-
ity of ClSO3H is to promote the synthesis of 2-aryl-1-aryl-
methyl-1H-benzimidazole azoles in various solvents. Among
these solvents and percentage (%) of yield and time required
is given in Table 1.
To show the merit of the present work in comparison with
reported results in the literature we compared results of chloro-
sulfonic acid with L-proline (Varala et al., 2007) and silica sulfu-
ric acid (Salehi et al., 2006) also yields are excellent in the
synthesis of some substituted 2-aryl-1-arylmethyl-1H-benzimi-
dazoles previously in the literature and were characterized by
the comparison of IR andNMR spectra with authentic samples.
4. Conclusion
In conclusion we have developed a new, efﬁcient, and im-
proved procedure for the synthesis of 2-aryl-1-arylmethyl-
1H-benzimidazole catalyzed by ClSO3H. Its advantages are,
the catalyst is inexpensive, easily available, and excellent yields
are obtained.Acknowledgment
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